Sort
64,565 grants matching “drug discovery”
Center on Intersystem Regulation by Drugs of Abuse
$1,406,934Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2019 · DA
Chemical Countermeasures Collaboration: Chemical Threats Affecting Cellular Respiration
$1,406,499Office Of The Director, National Institutes Of Health · Y01 · FY2025 · OD
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
$1,406,355Steven Hou · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Research Infrastructure Core
$1,406,183Yanyuan Wu · Charles R. Drew University Of Med & Sci · U54 · FY2022 · MD
NEW DRUG TARGETS FOR APOPTOSIS
$1,405,759University Of Arizona · P01 · FY2004 · CA
UCLA CENTER FOR DIETARY SUPPLEMENTS RESEARCH: BOTANICALS
$1,405,743University Of California Los Angeles · P50 · FY2001 · AT
Use of systems pharmacology to prevent rod and cone photoreceptor degeneration
$1,405,643Krzysztof Palczewski · University Of California-Irvine · R24 · FY2021 · EY
Use of systems pharmacology to prevent rod and cone photoreceptor degeneration
$1,405,643Krzysztof Palczewski · University Of California-Irvine · R24 · FY2019 · EY
Use of systems pharmacology to prevent rod and cone photoreceptor degeneration
$1,405,643Krzysztof Palczewski · University Of California-Irvine · R24 · FY2020 · EY
Discovery of Anticancer Agents of Diverse Natural Origin
$1,405,544Alan Douglas Kinghorn · Ohio State University · P01 · FY2016 · CA
Discovery of Anticancer Agents of Diverse Natural Origin
$1,405,544Alan Douglas Kinghorn · Ohio State University · P01 · FY2017 · CA
Overcoming resistance to BRAF(V600E) targeted therapies in melanoma
$1,405,454David E Fisher · Massachusetts General Hospital · P01 · FY2015 · CA
DartCF: The Dartmouth Cystic Fibrosis Research Center
$1,405,453Dean R Madden · Dartmouth College · P30 · FY2022 · DK
Cocaine and Polydrug Abuse: New Medication Strategies
$1,404,528Mc Lean Hospital (Belmont, Ma) · P01 · FY2002 · DA
Automation and validation of human on a chip systems for drug discovery
$1,404,459Michael L Shuler · Hesperos, Llc · R44 · FY2020 · TR
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
$1,403,852Matthew J Ellis · Baylor College Of Medicine · U01 · FY2020 · CA
Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease
$1,403,321Shijun Zhang · Virginia Commonwealth University · U01 · FY2024 · AG
Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease
$1,403,321Shijun Zhang · Virginia Commonwealth University · U01 · FY2023 · AG
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
$1,403,277Linda J Van Eldik · University Of Kentucky · R01 · FY2019 · AG
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal
$1,403,277Matthew G Dorsey · University Of California, San Francisco · U19 · FY2018 · AI
Discovery of Novel Drugs for Alzheimer's Disease
$1,403,237James W. Simpkins · University Of North Texas Hlth Sci Ctr · P01 · FY2009 · AG
Malaria Drug Resistance and Disease Virulence
$1,402,631Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,402,526Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
$1,402,503Bernard Mark Evers · University Of Kentucky · P30 · FY2013 · CA
Core 1
$1,402,129Mark A Musen · Stanford University · U54 · FY2012 · HG